Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $384.88 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Vision LLC | $102.20 | 1 | $0 (2019) |
| ABBVIE INC. | $102.11 | 1 | $0 (2022) |
| Horizon Therapeutics plc | $86.98 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $45.98 | 3 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $27.63 | 1 | $0 (2021) |
| Shire North American Group Inc | $19.98 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $101.90 | 2 | Horizon Therapeutics plc ($86.98) |
| 2022 | $102.11 | 1 | ABBVIE INC. ($102.11) |
| 2021 | $27.63 | 1 | Mallinckrodt Hospital Products Inc. ($27.63) |
| 2019 | $102.20 | 1 | Alcon Vision LLC ($102.20) |
| 2018 | $19.98 | 1 | Shire North American Group Inc ($19.98) |
| 2017 | $31.06 | 2 | Novartis Pharmaceuticals Corporation ($31.06) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/02/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $86.98 | General |
| Category: TEPEZZA | ||||||
| 04/03/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Ophthalmology | ||||||
| 08/25/2022 | ABBVIE INC. | VUITY (Drug) | Food and Beverage | In-kind items and services | $102.11 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/08/2021 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2019 | Alcon Vision LLC | AcrySof (Device) | Food and Beverage | In-kind items and services | $102.20 | General |
| Category: Ophthalmology | ||||||
| 09/21/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: OPTHALMICS | ||||||
| 12/13/2017 | Novartis Pharmaceuticals Corporation | DUREZOL (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/25/2017 | Novartis Pharmaceuticals Corporation | DUREZOL (Drug), ILEVRO | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 2,304 | 2,536 | $292,490 | $171,682 |
| 2022 | 10 | 2,501 | 2,811 | $327,340 | $188,879 |
| 2021 | 10 | 2,323 | 2,578 | $302,800 | $178,482 |
| 2020 | 9 | 2,262 | 2,502 | $293,655 | $165,575 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 1,329 | 1,385 | $180,450 | $115,492 | 64.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 332 | 489 | $51,445 | $30,954 | 60.2% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 145 | 152 | $19,000 | $6,980 | 36.7% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 67 | 67 | $10,435 | $6,215 | 59.6% |
| 92133 | Imaging of optic nerve | Office | 2023 | 191 | 197 | $14,775 | $4,995 | 33.8% |
| 92134 | Imaging of retina | Office | 2023 | 123 | 126 | $9,450 | $3,717 | 39.3% |
| 92250 | Photography of the retina | Office | 2023 | 61 | 62 | $2,540 | $1,798 | 70.8% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 19 | 19 | $1,995 | $1,082 | 54.2% |
| 67820 | Removal of eyelashes using forceps | Office | 2023 | 16 | 18 | $1,350 | $272.52 | 20.2% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 21 | 21 | $1,050 | $176.82 | 16.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 1,351 | 1,406 | $183,280 | $116,915 | 63.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 434 | 662 | $70,010 | $41,811 | 59.7% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 128 | 128 | $20,040 | $11,089 | 55.3% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 156 | 163 | $20,375 | $7,508 | 36.9% |
| 92133 | Imaging of optic nerve | Office | 2022 | 210 | 218 | $16,350 | $5,452 | 33.3% |
| 92134 | Imaging of retina | Office | 2022 | 123 | 127 | $9,525 | $3,741 | 39.3% |
| 92002 | New patient problem focused exam of visual system | Office | 2022 | 26 | 26 | $2,730 | $1,356 | 49.7% |
| 67820 | Removal of eyelashes using forceps | Office | 2022 | 21 | 29 | $2,175 | $432.99 | 19.9% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2022 | 17 | 17 | $1,105 | $298.05 | 27.0% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 35 | 35 | $1,750 | $275.43 | 15.7% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 1,306 | 1,358 | $176,740 | $112,329 | 63.6% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 382 | 575 | $60,475 | $35,964 | 59.5% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 118 | 118 | $18,340 | $12,687 | 69.2% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 141 | 144 | $18,000 | $6,534 | 36.3% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 167 | 171 | $12,825 | $4,488 | 35.0% |
About Dr. Michael Radoiu, O.D
Dr. Michael Radoiu, O.D is a Optometrist healthcare provider based in Harrisonburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083620538.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Radoiu, O.D has received a total of $384.88 in payments from pharmaceutical and medical device companies, with $101.90 received in 2023. These payments were reported across 8 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($384.88).
As a Medicare-enrolled provider, Radoiu has provided services to 9,390 Medicare beneficiaries, totaling 10,427 services with total Medicare billing of $704,619. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Harrisonburg, VA
- Active Since 08/01/2006
- Last Updated 04/01/2010
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1083620538
Products in Payments
- AcrySof (Device) $102.20
- VUITY (Drug) $102.11
- TEPEZZA (Drug) $86.98
- XIIDRA (Drug) $34.90
- DUREZOL (Drug) $31.06
- ACTHAR (Biological) $27.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Harrisonburg
Dr. Robert Welch, O.d, O.D
Optometrist — Payments: $2,226
Dr. Michael Gowen, Od, OD
Optometrist — Payments: $1,799
Dr. Joseph Digirolamo, O.d, O.D
Optometrist — Payments: $1,080
Dr. Diane Hudson, O.d, O.D
Optometrist — Payments: $1,027
Dr. Katherine Welch, O.d, O.D
Optometrist — Payments: $867.91
Mrs. Casey Winpigler, O.d, O.D
Optometrist — Payments: $98.94